STWX:SW:SW-SPDR® MSCI Europe Health Care UCITS ETF CHF (CHF)

ETF | Others |

Last Closing

USD 210.75

Change

-1.15 (-0.54)%

Market Cap

USD 0.64B

Volume

15.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
RGLDS:SW Raiffeisen ETF Solid Gold A US..

-7.00 (-0.10%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-13.00 (-0.27%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+5.20 (+0.35%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

-22.80 (-1.14%)

USD 134,034.85B
SX7EEX:SW iShares EURO STOXX Banks 30-15..

N/A

USD 6,289.31B
TDXPEX:SW iShares TecDAX® UCITS ETF (DE..

+0.19 (+0.66%)

USD 5,933.97B
SMIEX:SW iShares SLI UCITS ETF (DE)

+1.20 (+0.94%)

USD 5,933.96B
DJSXE:SW iShares Core EURO STOXX 50 UCI..

N/A

USD 5,933.96B
DAXEX:SW iShares Core DAX® UCITS ETF (..

+0.52 (+0.36%)

USD 5,933.93B
MDAXEX:SW iShares MDAX® UCITS ETF (DE) ..

+0.10 (+0.05%)

USD 5,933.92B

ETFs Containing STWX:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.80% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.80% 85% B 84% B
Trailing 12 Months  
Capital Gain 6.04% 44% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.04% 44% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.61% 51% F 51% F
Dividend Return 1.61% 50% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.52% 67% D+ 71% C-
Risk Adjusted Return 45.83% 53% F 56% F
Market Capitalization 0.64B 70% C- 66% D+

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike